Evobrutinib-[d5]

Evobrutinib-[d5] is an isotope labelled Evobrutinib, a Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity, which is in clinical development to investigate its potential as a treatment for multiple sclerosis (MS).
Supplier BOC Sciences
Product # BLP-013475
Pricing Inquire
Molecular Weight 434.25
Molecular Formula C25H22D5N5O2
Feedback